Predictive Oncology Inc. (POAI)
NASDAQ: POAI · IEX Real-Time Price · USD
1.090
-0.080 (-6.84%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Predictive Oncology Market Cap
Predictive Oncology has a market cap or net worth of $4.47 million as of July 22, 2024. Its market cap has decreased by -76.83% in one year.
Market Cap
4.47M
Enterprise Value
1.88M
1-Year Change
-76.83%
Ranking
Category
Stock Price
$1.09
Market Cap Chart
Since May 3, 2010, Predictive Oncology's market cap has increased from $4.20M to $4.47M, an increase of 6.46%. That is a compound annual growth rate of 0.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 4.50M | -66.42% |
| Dec 29, 2023 | 13.40M | -44.40% |
| Dec 30, 2022 | 24.10M | -61.38% |
| Dec 31, 2021 | 62.40M | 383.72% |
| Dec 31, 2020 | 12.90M | 27.72% |
| Dec 31, 2019 | 10.10M | 16.09% |
| Dec 31, 2018 | 8.70M | 38.10% |
| Dec 29, 2017 | 6.30M | -33.68% |
| Dec 30, 2016 | 9.50M | -37.91% |
| Dec 31, 2015 | 15.30M | -21.94% |
| Dec 31, 2014 | 19.60M | -67.17% |
| Dec 31, 2013 | 59.70M | 401.68% |
| Dec 31, 2012 | 11.90M | 40.00% |
| Dec 30, 2011 | 8.50M | 466.67% |
| Dec 31, 2010 | 1.50M | -64.29% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exicure | 4.63M |
| Adial Pharmaceuticals | 4.61M |
| Evoke Pharma | 4.57M |
| Portage Biotech | 4.53M |
| Theriva Biologics | 4.53M |
| Genetic Technologies | 4.47M |
| Sonnet BioTherapeutics Holdings | 4.44M |
| Hoth Therapeutics | 4.41M |